Bei Zhang

Bei Zhang

Company: Novo Nordisk

Job title: Corporate Vice President


CagriSemi for Weight Management – From Discovery to the Clinic 9:00 am

CagriSema combines the actions of semaglutide and cagrilintide to improve several aspects of metabolism CagriSema displays dual efficacy of robust glycaemic control and body weight loss Weight loss of a higher magnitude contributes to additional glycaemic control and may have potential disease modifying effectsRead more

day: Conference Day 1

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.